Viewing Study NCT06825858

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 12:20 AM

Ignite Modification Date: 2025-12-25 @ 10:24 PM

Study NCT ID: NCT06825858

Status: NOT_YET_RECRUITING

Last Update Posted: 2025-02-13

First Post: 2025-02-08

Is Possible Gene Therapy: True

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: A Phase I, Open-label, Multicenter, Dose-Escalating Study to Evaluate the Safety and Tolerability of KH658 Gene Therapy in Participants with Neovascular Age-related Macular Degeneration

Sponsor: Chengdu Origen Biotechnology Co., Ltd.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module